{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T00:12:49Z","timestamp":1761005569711,"version":"build-2065373602"},"reference-count":35,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,10,20]],"date-time":"2025-10-20T00:00:00Z","timestamp":1760918400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Gastroenterol."],"abstract":"<jats:sec><jats:title>Background<\/jats:title><jats:p>Accurate and non-invasive diagnostics of celiac disease are essential for effective patient management. Although small intestine biopsy remains the diagnostic gold standard, serological assays offer a promising alternative. This study evaluated the performance and concordance of immunoblot, indirect immunofluorescence test (IIFT), and enzyme-linked immunosorbent assay (ELISA) in detecting celiac disease-specific autoantibodies in a Tunisian cohort, aiming to assess the potential of combining various assays to reduce reliance on invasive procedures.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>Serum samples from 80 celiac disease patients and appropriate controls were analyzed using three serological methods. IIFT was employed to detect IgA autoantibodies against endomysium using primate liver and human umbilical cord substrates. ELISA was used to quantify anti-tissue transglutaminase (tTG) IgA and deamidated gliadin peptide (DGP) autoantibodies. Immunoblots assessed additional autoantibodies (tTG, GAF-3X, and ASCA), along with further evaluation of IgG autoantibodies (intrinsic factor and parietal cell antibodies). Concordance among methods was evaluated.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>IIFT detected anti-endomysium IgA autoantibodies in 100% (80\/80) of celiac patients (in this cohort), with no positivity in controls. ELISA demonstrated that both tTG IgA and DGP autoantibodies were present in all celiac disease patients. All controls (n = 158) were ELISA-negative, indicating 100% specificity in both assays. Immunoblots revealed tTG IgA in 99% (79\/80) of patients, while GAF-3X autoantibodies were detected in 94% (IgA) and 85% (IgG) of celiac patients. In addition, ASCA IgA autoantibodies were present in 31% of celiac disease patients, with minimal reactivity observed in controls. A Venn diagram illustrated high concordance among the assays for tTG autoantibody detection, reinforcing the reliability of this autoantibody marker.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>The robust and consistent detection of celiac disease-specific autoantibodies, particularly tTG IgA and DGP autoantibodies, across multiple serological platforms underscores their diagnostic utility. The high concordance among these markers supports the potential of combined autoantibody testing to serve as a non-invasive alternative to biopsy, thereby enhancing clinical management of celiac disease.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fgstr.2025.1619533","type":"journal-article","created":{"date-parts":[[2025,10,20]],"date-time":"2025-10-20T05:24:27Z","timestamp":1760937867000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Prevalence of celiac disease in a Tunisian cohort"],"prefix":"10.3389","volume":"4","author":[{"given":"Mariam","family":"Ghozzi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marco","family":"Kai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tanja","family":"Seifert","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sarra","family":"Melayah","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fatma","family":"Mechi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sarra","family":"Romdhani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zeineb Ben","family":"Chedly","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ibtissem","family":"Ghedira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2025,10,20]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM200108023450506","article-title":"Autoimmune diseases","volume":"345","author":"MacKay","year":"2001","journal-title":"N Engl J Med"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1038\/jhg.2010.120","article-title":"Mixed origin of the current Tunisian population from the analysis of Alu and Alu\/STR compound systems","volume":"55","author":"El Moncer","year":"2010","journal-title":"J Hum Genet"},{"key":"B3","doi-asserted-by":"publisher","first-page":"4654","DOI":"10.1038\/s41598-024-54749-8","article-title":"Ethnic and functional differentiation of copy number polymorphisms in Tunisian and HapMap population unveils insights on genome organizational plasticity","volume":"14","author":"Romdhane","year":"2024","journal-title":"Sci Rep"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra071600","article-title":"Celiac disease","volume":"357","author":"Green","year":"2007","journal-title":"N Engl J Med"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v18.i42.6036","article-title":"Celiac disease: prevalence, diagnosis, pathogenesis and treatment","volume":"18","author":"Gujral","year":"2012","journal-title":"World J Gastroenterol"},{"key":"B6","doi-asserted-by":"publisher","first-page":"53","DOI":"10.5409\/wjcp.v10.i4.53","article-title":"Celiac disease in children: A review of the literature","volume":"10","author":"Sahin","year":"2021","journal-title":"World J Clin Pediatr"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1097\/MEG.0b013e328133f0c1","article-title":"Prevalence of celiac disease in Tunisia: mass-screening study in schoolchildren","volume":"19","author":"Hariz","year":"2007","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1097\/MPG.0b013e31815ce5d1","article-title":"Prevalence of celiac disease in Egyptian children disputes the east-west agriculture-dependent spread of the disease","volume":"47","author":"Abu-Zekry","year":"2008","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"B9","article-title":"Prevalence of celiac disease among blood donors in sistan and balouchestan province, southeastern Iran","volume":"13","author":"Bahari","year":"2010","journal-title":"Arch Iran Med"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1016\/j.dld.2011.01.002","article-title":"Coeliac disease in Libyan children: a screening study based on the rapid determination of anti-transglutaminase antibodies","volume":"43","author":"Alarida","year":"2011","journal-title":"Dig Liver Dis"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v19.i15.2374","article-title":"Seroprevalence of celiac disease among healthy adolescents in Saudi Arabia","volume":"19","author":"Aljebreen","year":"2013","journal-title":"World J Gastroenterol"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1155\/2020\/6865917","article-title":"The epidemiology of celiac disease in the general population and high-risk groups in arab countries: A systematic review","volume":"2020","author":"El-Metwally","year":"2020","journal-title":"BioMed Res Int"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2017.00137","article-title":"New insights into the pathogenesis of celiac disease","volume":"4","author":"De Re","year":"2017","journal-title":"Front Med (Lausanne)"},{"key":"B14","doi-asserted-by":"publisher","first-page":"5566","DOI":"10.1038\/s41598-022-09346-y","article-title":"Nutrient intake differs among persons with celiac disease and gluten-related disorders in the United States","volume":"12","author":"Unalp-Arida","year":"2022","journal-title":"Sci Rep"},{"key":"B15","doi-asserted-by":"publisher","first-page":"59","DOI":"10.14309\/ajg.0000000000002075","article-title":"American college of gastroenterology guidelines update: diagnosis and management of celiac disease","volume":"118","author":"Rubio-Tapia","year":"2023","journal-title":"Am J Gastroenterol"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.4253\/wjge.v5.i11.527","article-title":"Sedation-related complications in gastrointestinal endoscopy","volume":"5","author":"Amornyotin","year":"2013","journal-title":"World J Gastrointest Endosc"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2015.03.022","article-title":"Cost effectiveness of routine duodenal biopsy analysis for celiac disease during endoscopy for gastroesophageal reflux","volume":"13","author":"Yang","year":"2015","journal-title":"Clin Gastroenterol Hepatol"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1055\/a-1551-3343","article-title":"Gastrointestinal endoscopy capacity in Eastern Africa","volume":"9","author":"Mwachiro","year":"2021","journal-title":"Endosc Int Open"},{"key":"B19","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1016\/j.gie.2022.04.024","article-title":"Adverse events associated with EGD and EGD-related techniques","volume":"96","author":"Coelho-Prabhu","year":"2022","journal-title":"Gastrointest Endosc"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1136\/gut.47.5.628","article-title":"Development of a novel rapid non-invasive screening test for coeliac disease","volume":"47","author":"Baldas","year":"2000","journal-title":"Gut"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1128\/CVI.13.2.187-192.2006","article-title":"Performance of antibodies against tissue transglutaminase for the diagnosis of celiac disease: meta-analysis","volume":"13","author":"Zintzaras","year":"2006","journal-title":"Clin Vaccine Immunol"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v28.i1.154","article-title":"Current guidelines for the management of celiac disease: A systematic review with comparative analysis","volume":"28","author":"Raiteri","year":"2022","journal-title":"World J Gastroenterol"},{"key":"B23","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1177\/2050640619844125","article-title":"European Society for the Study of Coeliac Disease (ESsCD) guideline for coeliac disease and other gluten-related disorders","volume":"7","author":"Al-Toma","year":"2019","journal-title":"United Eur Gastroenterol J"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1111\/apt.16729","article-title":"Systematic review with meta-analysis: the accuracy of serological tests to support the diagnosis of coeliac disease","volume":"55","author":"Sheppard","year":"2022","journal-title":"Aliment Pharmacol Ther"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1097\/MPG.0000000000002497","article-title":"European society paediatric gastroenterology, hepatology and nutrition guidelines for diagnosing coeliac disease 2020","volume":"70","author":"Husby","year":"2020","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1023\/A:1019926121972","article-title":"Diagnostic value of anti-saccharomyces cerevisiae and antineutrophil cytoplasmic antibodies for inflammatory bowel disease: high prevalence in patients with celiac disease","volume":"22","author":"Damoiseaux","year":"2002","journal-title":"J Clin Immunol"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v9.i10.2308","article-title":"Seroreactivity against Saccharomyces cerevisiae in patients with Crohn\u2019s disease and celiac disease","volume":"9","author":"Barta","year":"2003","journal-title":"World J Gastroenterol"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1097\/00042737-200601000-00013","article-title":"Disappearance of anti-Saccharomyces cerevisiae antibodies in coeliac disease during a gluten-free diet","volume":"18","author":"Mallant","year":"2006","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1016\/j.cca.2010.02.060","article-title":"Diagnostic performance of IgG anti-deamidated gliadin peptide antibody assays is comparable to IgA anti-tTG in celiac disease","volume":"411","author":"Vermeersch","year":"2010","journal-title":"Clin Chim Acta"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.4103\/jfmpc.jfmpc_326_22","article-title":"Diagnostic accuracy of anti\u2212DGP (IgG) for celiac disease","volume":"12","author":"Jafari","year":"2023","journal-title":"J Family Med Prim Care"},{"key":"B31","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1038\/s41575-023-00872-2","article-title":"Guidelines for best practices in monitoring established coeliac disease in adult patients","volume":"21","author":"Elli","year":"2024","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.3390\/cancers16071310","article-title":"Autoimmune atrophic gastritis: A clinical review","volume":"16","author":"Castellana","year":"2024","journal-title":"Cancers (Basel)"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.3390\/diagnostics14161721","article-title":"Improving the diagnosis of autoimmune gastritis: from parietal cell antibodies to H+\/K+ ATPase antibodies","volume":"14","author":"Tonegato","year":"2024","journal-title":"Diagnostics (Basel)"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1001\/jama.282.11.1061","article-title":"Empirical evidence of design-related bias in studies of diagnostic tests","volume":"282","author":"Lijmer","year":"1999","journal-title":"JAMA"},{"key":"B35","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1016\/j.jclinepi.2008.04.007","article-title":"Diagnostic test accuracy may vary with prevalence: implications for evidence-based diagnosis","volume":"62","author":"Leeflang","year":"2009","journal-title":"J Clin Epidemiol"}],"container-title":["Frontiers in Gastroenterology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fgstr.2025.1619533\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,20]],"date-time":"2025-10-20T05:24:27Z","timestamp":1760937867000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fgstr.2025.1619533\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,20]]},"references-count":35,"alternative-id":["10.3389\/fgstr.2025.1619533"],"URL":"https:\/\/doi.org\/10.3389\/fgstr.2025.1619533","relation":{},"ISSN":["2813-1169"],"issn-type":[{"value":"2813-1169","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,20]]},"article-number":"1619533"}}